Charles Kasiewski

528 total citations
17 papers, 334 citations indexed

About

Charles Kasiewski is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine. According to data from OpenAlex, Charles Kasiewski has authored 17 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Hematology and 6 papers in Internal Medicine. Recurrent topics in Charles Kasiewski's work include Blood Coagulation and Thrombosis Mechanisms (8 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Charles Kasiewski is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (8 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Charles Kasiewski collaborates with scholars based in United States, Sweden and Switzerland. Charles Kasiewski's co-authors include Mark H. Perrone, Robert J. Leadley, Ross Bentley, Christopher T. Dunwiddie, Glenda E. Bilder, Valeria Chu, Jeffrey S. Bostwick, Karen Brown, Alfred P. Spada and Scott I. Klein and has published in prestigious journals such as Circulation, Journal of Medicinal Chemistry and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Charles Kasiewski

17 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Kasiewski United States	13	142	100	79	79	62	17	334
Susan G. Panzer‐Knodle United States	12	212 1.5×	135 1.4×	72 0.9×	259 3.3×	117 1.9×	18	561
Julio C. Reséndiz Finland	10	156 1.1×	69 0.7×	44 0.6×	229 2.9×	85 1.4×	14	396
M. Ya. Ruda Russia	10	242 1.7×	66 0.7×	16 0.2×	49 0.6×	36 0.6×	30	418
SaeHeum Song United States	9	133 0.9×	214 2.1×	65 0.8×	28 0.4×	32 0.5×	18	501
E. Széll Hungary	6	29 0.2×	175 1.8×	20 0.3×	156 2.0×	40 0.6×	15	342
Masahide Nakajima Japan	12	27 0.2×	240 2.4×	9 0.1×	20 0.3×	50 0.8×	28	438
Masato Komoda Japan	11	16 0.1×	183 1.8×	13 0.2×	36 0.5×	38 0.6×	32	408
Johnny Yu United States	6	33 0.2×	205 2.0×	31 0.4×	58 0.7×	12 0.2×	9	337
Beatriz Sánchez-Vega Spain	12	106 0.7×	78 0.8×	5 0.1×	125 1.6×	18 0.3×	18	421

Countries citing papers authored by Charles Kasiewski

Since Specialization

Citations

This map shows the geographic impact of Charles Kasiewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Kasiewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Kasiewski more than expected).

Fields of papers citing papers by Charles Kasiewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Kasiewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Kasiewski. The network helps show where Charles Kasiewski may publish in the future.

Co-authorship network of co-authors of Charles Kasiewski

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Kasiewski. A scholar is included among the top collaborators of Charles Kasiewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Kasiewski. Charles Kasiewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Rebello, Sam, Charles Kasiewski, Ross Bentley, et al.. (2001). Superiority of Enoxaparin Over Heparin in Combination With a GPIIb/IIIa Receptor Antagonist During Coronary Thrombolysis in Dogs. Thrombosis Research. 102(3). 261–271. 13 indexed citations

Rebello, Sam, Charles Kasiewski, Wei Wang, et al.. (2001). Role of Short-Term Inhibition of Factor Xa by FXV673 in Arterial Passivation: A Study in a Chronic Model of Thrombosis in Conscious Dogs. Journal of Cardiovascular Pharmacology. 38(2). 288–297. 9 indexed citations

Rebello, Sam, Ross Bentley, Charles Kasiewski, et al.. (2001). Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis. British Journal of Pharmacology. 133(7). 1190–1198. 20 indexed citations

Chu, Valeria, Karen Brown, Dennis Colussi, et al.. (2001). Pharmacological Characterization of a Novel Factor Xa Inhibitor, FXV673. Thrombosis Research. 103(4). 309–324. 23 indexed citations

Heran, Christopher L., Charles Kasiewski, Jeffrey S. Bostwick, et al.. (2000). Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis. European Journal of Pharmacology. 389(2-3). 201–207. 23 indexed citations

Becker, Michael R., William R. Ewing, Henry W. Pauls, et al.. (1999). Synthesis, SAR and in vivo activity of novel thienopyridine sulfonamide pyrrolidinones as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(18). 2753–2758. 19 indexed citations

Leadley, Robert J., Ross Bentley, Jeffrey S. Bostwick, et al.. (1999). Pharmacodynamic Activity and Antithrombotic Efficacy of RPR120844, a Novel Inhibitor of Coagulation Factor Xa. Journal of Cardiovascular Pharmacology. 34(6). 791–799. 15 indexed citations

Bilder, Glenda E., Robert J. Leadley, Dilip Amin, et al.. (1999). Restenosis Following Angioplasty in the Swine Coronary Artery Is Inhibited By an Orally Active PDGF-Receptor Tyrosine Kinase Inhibitor, RPR101511A. Circulation. 99(25). 3292–3299. 79 indexed citations

Klein, Scott I., Bruce F. Molino, Valeria Chu, et al.. (1998). Design of a New Class of Orally Active Fibrinogen Receptor Antagonists. Journal of Medicinal Chemistry. 41(14). 2492–2502. 15 indexed citations

10.

Leadley, Robert J., Charles Kasiewski, Jeffrey S. Bostwick, et al.. (1998). Inhibition of Repetitive Thrombus Formation in the Stenosed Canine Coronary Artery by Enoxaparin, But Not by Unfractionated Heparin. Arteriosclerosis Thrombosis and Vascular Biology. 18(6). 908–914. 21 indexed citations

11.

Leadley, Robert J., Charles Kasiewski, Jeffrey S. Bostwick, et al.. (1997). Comparison of Enoxaparin, Hirulog, and Heparin as Adjunctive Antithrombotic Therapy during Thrombolysis with rtPA in the Stenosed Canine Coronary Artery. Thrombosis and Haemostasis. 78(4). 1278–1285. 18 indexed citations

12.

Bostwick, Jeffrey S., Charles Kasiewski, Valeria Chu, et al.. (1996). Anti-thrombotic activity of RG13965, a novel platelet fibrinogen receptor antagonist. Thrombosis Research. 82(6). 495–507. 8 indexed citations

13.

Klein, Scott I., Jeffrey M. Dener, Bruce F. Molino, et al.. (1996). O-benzyl hydroxyproline as a bioisostere for Phe-Pro: Novel dipeptide thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 6(18). 2225–2230. 10 indexed citations

14.

Bilder, Glenda E., et al.. (1993). Electrode cuff-induced changes in DNA and PDGF gene expression in the rat carotid artery. Atherosclerosis. 100(1). 103–112. 8 indexed citations

15.

Bilder, Glenda E., et al.. (1993). PDGF‐receptor protein tyrosine kinase activity in carotid artery is enhanced by injury and inhibited in vivo by tyrphostin RG 13291. Drug Development Research. 29(2). 158–166. 15 indexed citations

16.

Barrett, John, et al.. (1990). Pharmacology of RG W-2938: A Cardiotonic Agent with Vasodilator Activity. Journal of Cardiovascular Pharmacology. 16(4). 537–545. 22 indexed citations

17.

Bilder, Glenda E., Charles Kasiewski, & Mark H. Perrone. (1990). Phorbol-12,13-dibutyrate-induced vasoconstriction in vivo: characterization of response in genetic hypertension.. Journal of Pharmacology and Experimental Therapeutics. 252(2). 526–530. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact